Strangvac

Land: Europäische Union

Sprache: Litauisch

Quelle: EMA (European Medicines Agency)

Wirkstoff:

Recombinant Streptococcus equi protein CCE, Recombinant Streptococcus equi protein Eq85, Recombinant Streptococcus equi protein IdeE

Verfügbar ab:

Intervacc AB

ATC-Code:

QI05AB01

INN (Internationale Bezeichnung):

Streptococcus equi vaccine (recombinant proteins)

Therapiegruppe:

Arkliai

Therapiebereich:

Arklinių šeimos gyvūnų imunologai

Anwendungsgebiete:

For the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with S. equi.

Berechtigungsstatus:

Įgaliotas

Berechtigungsdatum:

2021-08-16

Gebrauchsinformation

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Naujausia informacija apie šį veterinarinį vaistą pateikiama
veterinarinių vaistų informacijos svetainėje.

Fachinformation

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Naujausia informacija apie šį veterinarinį vaistą pateikiama
veterinarinių vaistų informacijos svetainėje.